ResearchGuide Logo

Chat support

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Quartille





Expert Review of Vaccines

VERIFIED JOURNAL
You want to contribute ? Login first and send us the Journal infos you think is correct.
We would be pleased to have your collaboration

This journal is included in the ResearchGuide whitelist of reputable titles. Learn more here.

JOURNAL INFORMATION
Publisher Taylor and Francis Ltd.
Open Access NO
Quartile Q1
Citation Count 1675
P-ISSN 1476-0584
E-ISSN 1744-8395
Categories Drug Discovery, Immunology, Molecular Medicine, Pharmacology
Area Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Pharmacology, Toxicology and Pharmaceutics
Region Western Europe
Country United Kingdom
Summary

  1. Expert Review of Vaccines is published by Taylor and Francis Ltd.
  2. It is not an oppen access journal
  3. The Subject Area : Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Pharmacology, Toxicology and Pharmaceutics

Latest Articles published

Last updated: 20/11/2024

Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers


Last updated: 19/11/2024

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan


Last updated: 18/11/2024

Adult vaccination in three Eastern Mediterranean countries: current status, challenges and the way forward


Last updated: 18/11/2024

Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment


Last updated: 15/11/2024

Hookworm vaccines: current and future directions


Last updated: 13/11/2024

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the omicron BA.2.86/JN.1 period among older adults in seven European countries: a VEBIS-EHR network study


Last updated: 11/11/2024

Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial


Last updated: 29/10/2024

Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review


Last updated: 25/10/2024

Cost-effectiveness of cell-based influenza vaccine in France


Last updated: 22/10/2024

Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial